Skip to main content
Clinical Trials/ITMCTR2200006862
ITMCTR2200006862
Not Yet Recruiting
N/A

Clinical observation and mechanism exploration of Guben Xiaozhen recipe in the treatment of chronic spontaneous urticaria

Guangdong Provincial Hospital of Chinese Medicine0 sitesTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
chronic urticaria
Sponsor
Guangdong Provincial Hospital of Chinese Medicine
Status
Not Yet Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
Guangdong Provincial Hospital of Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • (1\)Clinical diagnosis of patients with chronic spontaneous urticaria, the degree of disease is moderate to severe (16\=UAS7\=42\).
  • (2\)Male and female aged 18 to 65 years old.
  • (3\)Patients with syndrome pattern of Wei qi deficiency.
  • (4\)To be able to and willing to provide signed informed consent.

Exclusion Criteria

  • (1\) he occurrence of chronic urticaria is severe, such as the appearance of chest stuffy, wheezing, breathing difficulties, and the choking of the laryngeal mucosa. Accompanied by high fever, cold war,tachycardia, etc.
  • (2\) Pregnant,lactating women or pregnancy is planned in half a year.
  • (3\) Patients with psychiatric disorders;
  • (4\) Patients with other skin diseases that require treatment currently, with history of primary cardiovascular, respiratory, digestive, urinary, endocrinologic and hematologic diseases, which can't be controlled through ordinary treatments.patients with malignant tumor. Patients with clinical test results listed below: AST or ALT 3 times more than normal upper limit; Creatinine 3 times more than normal upper limit;Or any other abnormal laboratory test results, assessed by investigators, that are not suitable for this clinical study.
  • (5\) Topical treatments with antihistamines or chinese medicine within 1 week; Oral hormones and other immunosuppressive drugs, immunoglobulins and autohemotherapy within 4 weeks; biological therapy or inject glucocorticoid drugs within 12 weeks.
  • (6\) Allergic to this drug ingredient.
  • (7\) Participating other clinical trials.

Outcomes

Primary Outcomes

Not specified

Similar Trials